Objective To investigate the therapeutic effects of Guanxinning tablets on cerebral-cardiac syndrome in patients with intracere-bral hemorrhage.Methods A retrospective analysis was performed on the medical records of patients with cerebral-cardiac syndrome who met the inclusion and exclusion criteria in our hospital from January 2023 to December 2023.The control group received standard treatment for intracerebral hemorrhage,while the experimental group received Guanxinning tablets.Cardiac function was assessed using myocardial enzymes,electrocardiogram,and echocardiography on the first and 30th days following hospital admission.Results A total of 94 patients were included in the study.The ex-perimental group demonstrated significant improvements in T wave changes,ST segment changes,atrial fibrillation,as well as elevations in creatine ki-nase isoenzyme and lactate dehydrogenase levels(P＜0.05).Conclusion Guanxinning tablets may be effective in treating cerebral-cardiac syndrome following intracerebral hemorrhage,particularly in improving arrhythmia and myocardial injury.
NETL
NSTL
万方数据
